Key facts
- Armodafinil vs modafinil in one line: modafinil (Provigil) is a 50:50 mix of two mirror-image molecules. Armodafinil (Nuvigil) contains only one of them, the longer-lasting R-form.
- Both are FDA-approved for the same three conditions in adults: excessive sleepiness from narcolepsy, obstructive sleep apnea (OSA) and shift work disorder.
- Usual label doses: modafinil 200 mg once a day; armodafinil 150 mg (shift work) or 150–250 mg (narcolepsy, OSA) once a day.
- Their terminal half-lives are about the same, but armodafinil keeps blood levels higher later in the day.
- Both are Schedule IV controlled substances, neither is approved for children, and both can make hormonal birth control less effective.
If your prescriber has mentioned Nuvigil after you have tried Provigil (covered in our modafinil guide), or your pharmacy has switched you from one generic to the other, you may wonder whether they are really different medicines. The short answer on armodafinil vs modafinil is that they are close relatives: armodafinil is one half of the modafinil molecule pair. That makes them alike in most ways that matter, with a few real differences in dosing, timing and how long the effect holds up through the day.
Armodafinil vs modafinil at a glance
| Modafinil (Provigil) | Armodafinil (Nuvigil) | |
|---|---|---|
| What it is | Racemic mix: equal parts R- and S-modafinil | R-modafinil only |
| FDA approval | December 1998 | June 2007 |
| Approved uses (adults) | Narcolepsy, OSA, shift work disorder | Narcolepsy, OSA, shift work disorder |
| US tablet strengths | 100 mg, 200 mg | 50, 150, 200, 250 mg |
| Usual label dose | 200 mg once daily | 150 mg (shift work); 150–250 mg (narcolepsy, OSA) |
| Terminal half-life | About 15 hours | About 15 hours |
| Late-day blood levels | Lower, because the S-form clears fast | Higher mg-for-mg |
| DEA schedule | Schedule IV | Schedule IV |
| Generic available in US | Yes | Yes |
What “enantiomer” means here
Many molecules come in two forms that are mirror images of each other, like your left and right hands. Chemists call these enantiomers. The Provigil prescribing information describes modafinil as a 1:1 mix of the R- and S-forms. The Nuvigil prescribing information describes armodafinil as the R-form alone.
The two forms are handled differently by the body. According to the Provigil label, the half-life of R-modafinil is about three times that of S-modafinil, and by the time the next dose is due, about 90% of the modafinil left in the blood is the R-form. In other words, much of the lasting effect of modafinil already comes from the same molecule that armodafinil supplies on its own.
The same idea shows up with sleep medicines: eszopiclone (Lunesta) is a single mirror-image form of zopiclone. Our guide to zopiclone vs eszopiclone explains that pair.
How long do they last?
This is where many websites get it wrong. Some say armodafinil has a longer half-life. The labels and the main pharmacology study say otherwise: both have a terminal half-life of roughly 15 hours.
The difference is in the shape of the blood-level curve. In a pooled analysis of studies in healthy adults, Darwish and colleagues (Clinical Drug Investigation, 2009) found similar peak levels and similar half-lives, but modafinil levels fell in two phases because the short-lived S-form cleared early. Milligram for milligram, armodafinil produced 33% to 40% more total drug exposure, so its levels stayed higher later in the day. The authors worked for the manufacturer and studied healthy volunteers, so the findings describe drug levels rather than how alert patients felt.
In plain terms: armodafinil may hold up a little better into the late afternoon or the end of a night shift. That is also why its usual dose (150 mg) is lower than modafinil’s (200 mg). The labels do not set an official conversion between the two, so any switch should be worked out with your prescriber.
Do they work differently?
Both drugs improve wakefulness; neither cures the underlying condition. The Nuvigil label points out that in OSA it treats the sleepiness, not the airway blockage, so CPAP or other OSA treatment should continue.
Only one randomized trial has compared them directly. In a 12-week, double-blind study of 211 people with shift work disorder, Tembe and colleagues (Neurology Research International, 2011) gave armodafinil 150 mg or modafinil 200 mg an hour before the night shift. About 72% of the armodafinil group and 74% of the modafinil group responded, a difference that was not statistically significant, and side effects were similar. The trial was run in India and covered shift work disorder only, so it does not settle every question, but it found no clear winner.
Dosing according to the FDA labels
These are the label doses, shown only so you can follow conversations with your care team. Never change your dose on your own.
- Modafinil: 200 mg once in the morning for narcolepsy or OSA, or about one hour before the start of the shift for shift work disorder. The label notes that doses up to 400 mg a day were tolerated in trials but gave no consistent extra benefit over 200 mg.
- Armodafinil: 150 mg to 250 mg once in the morning for narcolepsy or OSA, or 150 mg about one hour before the shift for shift work disorder.
- Liver disease and older adults: both labels call for a lower dose in severe liver impairment and suggest considering lower doses in older adults.
MedlinePlus adds practical points: take the dose at the time your prescriber sets (in the morning, or about an hour before a shift), remember that these medicines can be habit-forming, and keep in mind that they do not replace getting enough sleep or using CPAP.
Side effects compared
Because armodafinil is part of modafinil, their side effect lists are nearly identical. The labels report these figures from US clinical trials (drug vs placebo):
| Side effect | Modafinil vs placebo | Armodafinil vs placebo |
|---|---|---|
| Headache | 34% vs 23% | 17% vs 9% |
| Nausea | 11% vs 3% | 7% vs 3% |
| Stopped due to side effects | 8% vs 3% | 7% vs 4% |
The numbers come from different trials, so when weighing armodafinil vs modafinil they should not be read as proof that one drug causes fewer headaches. Armodafinil’s label also lists dizziness (5% vs 2%) and trouble sleeping (5% vs 1%). For a fuller list, including how to manage common effects, see our guide to modafinil side effects.
Both labels carry the same serious warnings:
- Serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
- DRESS (a drug reaction that can affect several organs) and other allergic reactions, including swelling of the face, lips or throat
- Psychiatric symptoms such as anxiety, mania, hallucinations or suicidal thoughts
- Chest pain, fast or irregular heartbeat, and blood pressure changes
- Persistent sleepiness, meaning you may still not be fully alert enough to drive safely
Get emergency help (call 911) if you have a rash with blisters or peeling skin, swelling of the face, lips, tongue or throat, trouble breathing, chest pain, or thoughts of harming yourself. For thoughts of suicide, call or text 988. If someone may have taken too much, call Poison Help at 1-800-222-1222.
Birth control, alcohol and other interactions
Both medicines speed up the breakdown of some other drugs. The most important example is hormonal birth control. The labels and MedlinePlus advise using a backup or non-hormonal method during treatment and for one month after the last dose. That applies to pills, patches, rings, implants, injections and hormonal IUDs. MedlinePlus also advises avoiding alcohol while taking these drugs.
Tell your prescriber and pharmacist about everything you take, including other stimulants, antidepressants, blood thinners such as warfarin, and seizure medicines.
Controlled substance status in the US
Modafinil is listed in Schedule IV under federal law, and the listing covers its isomers, which includes armodafinil (21 CFR 1308.14). Schedule IV means the drug has accepted medical use and a lower potential for misuse than Schedule II stimulants such as amphetamine, but it still needs a valid prescription and refills are limited. Both labels note that the drugs can produce effects like other stimulants and may be habit-forming.
If you have narcolepsy and want to know the lawful route from diagnosis to pharmacy counter, see how to buy modafinil for narcolepsy with a valid prescription.
Which one is right for you?
There is no one-size answer to armodafinil vs modafinil. Your prescriber may weigh:
- Timing of sleepiness: if alertness fades late in the day or near the end of a shift, armodafinil’s steadier levels may be a reason to try it.
- Dose options: armodafinil comes in four US strengths (50, 150, 200 and 250 mg), modafinil in two (100 and 200 mg).
- Side effects: someone who did not tolerate one may be offered the other, but because they share a molecule, a serious reaction to one (such as a severe rash) generally rules out both.
- Insurance coverage: both are available as generics, and plans often prefer one over the other.
Questions to ask your prescriber
- Why are you recommending modafinil or armodafinil for me, and what result should I expect?
- If I switch, what dose will I start on, and how will we judge whether it works better?
- What time of day should I take it, especially around my work shifts?
- Do any of my current medicines or my birth control interact with it?
- Which side effects should make me call you, and which mean I should stop and get help?
- Should I keep using CPAP or other treatments while taking it?
Frequently asked questions
Is armodafinil stronger than modafinil?
Milligram for milligram, armodafinil gives higher blood levels later in the day, which is why its usual dose is lower (150 mg versus 200 mg). In the only head-to-head trial, in shift work disorder, the two worked about equally well at their usual doses.
Does armodafinil last longer than modafinil?
Both have a terminal half-life of about 15 hours. Armodafinil keeps blood levels higher for more of the day because it does not contain the short-lived S-form found in modafinil, so its effect may hold up a little better into the afternoon or late in a shift.
Can I take modafinil and armodafinil together?
No, not unless a prescriber specifically directs it. Armodafinil is already part of modafinil, so taking both would simply mean taking more of the same drug and raising the risk of side effects.
Are modafinil and armodafinil controlled substances?
Yes. Both are Schedule IV controlled substances in the United States and require a valid prescription from a licensed prescriber.
Do modafinil and armodafinil affect birth control?
Yes. Both can make hormonal birth control less effective. Use a backup or non-hormonal method while taking either medicine and for one month after your last dose.
Related guides
- Modafinil Explained: Uses, How It Works and Safety
- Modafinil Side Effects: Common, Rare and When to Get Help
- Modafinil vs Adderall (and Vyvanse, Ritalin): How They Differ
- How to Buy Modafinil for Narcolepsy Treatment (Prescription Required)
- Zopiclone vs Eszopiclone (Lunesta): The US Equivalent Explained
- Modafinil for Narcolepsy: How It Treats Excessive Daytime Sleepiness
- Modafinil for Idiopathic Hypersomnia, ADHD and MS Fatigue: What the Evidence Says
- Is Modafinil a Controlled Substance? Schedule IV Explained
- How Modafinil Works: Mechanism, Half-Life and How Long It Lasts
- Modafinil Dosage: What the FDA Label Says
- Modafinil Interactions: Alcohol, Birth Control and Caffeine
- The “Smart Drug” Myth: Modafinil in Healthy People
- How to Get a Modafinil Prescription: Sleep Studies, Telehealth and Insurance
Sources
- Cephalon/Teva. NUVIGIL (armodafinil) tablets: Prescribing information. US Food and Drug Administration, 2017.
- Cephalon/Teva. PROVIGIL (modafinil) tablets: Prescribing information. US Food and Drug Administration, 2015.
- US Food and Drug Administration. Drugs@FDA: NUVIGIL (NDA 021875).
- US Food and Drug Administration. Drugs@FDA: PROVIGIL (NDA 020717).
- Darwish M, Kirby M, Hellriegel ET, Robertson P Jr. Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives. Clinical Drug Investigation. 2009;29(9):613-623.
- Tembe DV, et al. Armodafinil versus modafinil in patients of excessive sleepiness associated with shift work sleep disorder: a randomized double blind multicentric clinical trial. Neurology Research International. 2011.
- National Library of Medicine. Armodafinil: MedlinePlus Drug Information.
- National Library of Medicine. Modafinil: MedlinePlus Drug Information.
- Electronic Code of Federal Regulations. 21 CFR 1308.14: Schedule IV.
